[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit ::
Main Menu
Journal Information::
Editorial Policies::
Articles archive::
For Authors::
Contact us::
Site Facilities::
::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
Last site contents
:: Contact Us
:: Volume 32, Issue 3 And 4 (10-2020) ::
J Iran Dent Assoc 2020, 32(3 And 4): 83-88 Back to browse issues page
Oral Manifestations of Patients Taking Anti-Hypertensive Medications
Zahra Elmi Rankohi1 , Mohammad Shabanian2 , Donya Maleki * 3
1- O.M.M, Dental Sciences Research Center, Department of Oral and Maxillofacial Medicine, School of Dentistry, Gilan University of Medical Sciences, Rasht, Iran
2- DDS, Student Research Committee, Dental Research Center, Faculty of Dentistry, Guilan University of Medical Sciences, Rasht, Iran
3- Student Research Committee, Dental Research Center, Faculty of Dentistry, Guilan University of Medical Sciences, Rasht, Iran , donyamaleki93@gmail.com
Abstract:   (1806 Views)
Background and Aim: High blood pressure is a common cardiovascular disease. Most cardiovascular medications have adverse oral side effects. This study aimed to determine the prevalence of oral manifestations associated with the intake of anti-hypertensive medications.
Materials and Methods: This cross-sectional analytical study examined 142 patients with a history of hypertension referred to Dr. Heshmat Hospital in Rasht who were taking one of the four drug categories of diuretics, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, or beta-blockers. The patients' demographic information, medications, and oral symptoms such as mucosal burning, xerostomia, angioedema, and lichenoid reactions were recorded. The data were analyzed by SPSS version 24 using Fisher’s ex-act test and Chi-square test (P<0.05).
Results: From 142 participants, 103 were males and 39 were females; 58.4% of the participants were 61 years or older. Concomitant use of beta-blockers and angiotensin receptor blockers (especially metoprolol and losartan) had the highest frequency among patients. Xerostomia was the most common side effect; angioedema was not reported in any patient. The prevalence of xerostomia increased with age (P=0.044) but it was not correlated with gender (P=0.119). Lichenoid reactions and burning mouth were neither age-related nor gender-related (P>0.05 for all).
Conclusion: Oral complications are inevitable in patients taking anti-hypertensive medications, and in most cases it is not possible to change or decrease the dosage of medications. Therefore, regular dental examinations and palliative treatment can play a role in improving the patients' quality of life.
Keywords: Antihypertensive Agents, Mouth, Adverse Effects
Full-Text [PDF 632 kb]   (2700 Downloads)    
Type of Study: Original | Subject: Oral Medicine
References
1. Zips DP, Libby P, Bonow R, Braunwald E. Braunwald’s heart disease: A textbook of cardiovascular medicine. 7th ed. Philadelphia: W.B. Saunders, 2015:963-1007, 419-21.
2. Flynn JT. Hypertension in the young: epidemiology, sequelae and therapy. Nephrol Dial Transplant 2009 Feb;24(2):370-5.
3. Moore WE, Stephens A, Wilson T, Wilson W, Eichner JE. Peer reviewed: body mass index and blood pressure screening in a rural public school system: the Healthy Kids Project. Prev Chronic Dis. 2006 Oct;3(4):A114.
4. Sorof JM, Lai D, Turner J, Poffenbarger T, Portman RJ. Overweight, ethnicity, and the prevalence of hypertension in school-aged children. Pediatrics 2004 Mar;113(3 Pt 1):475- 82.
5. Dustan HP, Schneckloth RE, Corcoran AC. The effectiveness of long term treatment of malignant hypertension. Circulation 1958 Oct; 18(4 Part 1):644-51.
6. Beck JD, Offenbacher S. Systemic effects of periodontitis: epidemiology of periodontal disease and cardiovascular disease. J Periodontol 2005 Nov;76(11 Suppl):2089-100.
7. Vaughan CJ, Delanty N. Hypertensive emergencies. Lancet 2000;356:411-17.
8. Topel LA, Kragelund C, Reibel J, Nauntofte B. Oral adverse drug reactions to cardiovascular drugs. Crit Rev Oral Biol Med 2004 Jan; 15(1): 28-46.
9. Arunkumar SH, Kalappanavar AN, Annigeri RG, Shakunthala GK. Adverse oral manifestations of cardiovascular drugs. J Dent Med Sci 2013 Jun;7(5);64-71.
10. Bakhtiari S, Sehatpour M, Mortazavi H, Bakhshi M. Orofacial manifestations of adverse drug reactions: a review study. Clujul Med 2018 Jan;91(1):27-36.
11. Yuan A, Woo SB. Adverse drug events in the oral cavity. Oral Surg Oral Med Oral Pathol Oral Radiol 2015 Jan;119(1):35-47.
12. Femiano F, Lanza A, Buonaiuto C, Gombos F, Rullo R, Festa V, et al. Oral manifestations of adverse drug reactions: guidelines. J Eur Acad Dermatol Venereol 2008 Oct;22:681-91.
13. Pamlona MC, Soriano YJ, Perez MGS. Dental considerations in patients with heart disease. J clin Exp Dent 2011 Dec;3(2):e97-105.
14. Glick M, Feagans WM. Burket’s oral medicine. Shelton. 2015. 12th ed. Chap 4-6,10.
15. Sultana N, Sham EM. Xerostomia an overview. Int J Clin Dent. 2011 Apr;3(2):58-61.
16. Zavras AI, Rosenberg GE, Danielson JD, Cartsos VM. Adverse drug and device reactions in the oral cavity: surveillance and reporting. J Am Dent Assoc 2013 Sep; 144(9): 1014-21.
17. Edwards D, Boritz E, Cowen EW, Brown RS. Erythema multiforme major following treatment with infliximab. Oral Surg Oral Med Oral Pathol Oral Radiol 2013 Feb;115(2):e36- e40.
18. Jayakaran TG. The effect of drugs in the oral cavity - A review. J Pharm Sci Res 2014 Feb; 6 (2):89-96.
19. Habbab KM, Moles DR, Porter SR. Potential oral manifestations of cardiovascular drugs. Oral Dis 2010 Nov;16(8):769-73.
20. Kumar P, Mastan KM, Chowdhary R, Shanmugam K. Oral manifestations in hypertensive patients: A clinical study. J Oral Maxillofac Pathol 2012 May-Aug;16(2):215– 221.
21. Villa A, Abati S. Risk factors and symptoms associated with xerostomia: a cross-sectional study. Aust Dent J 2011 Sep;56(3):290-5.
22. Valizadeh GH-A, Bijani M, Bahramali E, Kouhpayeh A. Investigating the consistency rate of hypertension treatment through guide line JNC-7, in patients who were referred to health centers and health houses of Fasa University of Medical Sciences 2012. J Fasa Univ Med Sci 2014 Jun;4(1):74-80.
23. William J, Elliott MD. Drug interactions and drugs that affect blood pressure. J Clin Hypertens 2006 Oct;8(10):731-7.
24. Wright JM. Choosing a first – line drug in the management of elevated blood pressure: what is the evidence? CMAJ 2000 Jul;163(1):57-60.
25. Shirzaiy M, Bagheri F. Prevalence of xerostomia and its related factors in patients referred to Zahedan Dental School in Iran. DCEJ 2016 Feb;2(1):e7138.
26. Little JW, Falace DA, Miller CS, Rhodus NL. Drug and alcohol abuse: Dental management of the medically compromised patient. 8th ed. St Louis: Mosby Elsevier; 2018; 33-44: 562-75.
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA



XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Elmi Rankohi Z, Shabanian M, Maleki D. Oral Manifestations of Patients Taking Anti-Hypertensive Medications. J Iran Dent Assoc 2020; 32 (3 and 4) :83-88
URL: http://jida.ir/article-1-2120-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 32, Issue 3 And 4 (10-2020) Back to browse issues page
Journal of Iranian Dental Association

AWT IMAGE

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly

Persian site map - English site map - Created in 0.05 seconds with 37 queries by YEKTAWEB 4645